Arrow Greentech Ltd
Incorporated in 1982, Arrow Greentech
Ltd is in the business of bio-degradable (green) products, high-tech products and having Patents income for such products /technology[1]
- Market Cap ₹ 720 Cr.
- Current Price ₹ 477
- High / Low ₹ 818 / 342
- Stock P/E 17.0
- Book Value ₹ 147
- Dividend Yield 0.84 %
- ROCE 28.5 %
- ROE 20.9 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has delivered good profit growth of 76.6% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 30.7%
- Company's median sales growth is 18.6% of last 10 years
Cons
- Promoter holding has decreased over last 3 years: -3.77%
- Working capital days have increased from 155 days to 285 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20 | 23 | 31 | 39 | 43 | 31 | 27 | 24 | 106 | 132 | 201 | 157 | |
| 11 | 11 | 15 | 27 | 46 | 28 | 23 | 29 | 78 | 80 | 118 | 101 | |
| Operating Profit | 9 | 12 | 16 | 12 | -3 | 4 | 3 | -5 | 28 | 52 | 83 | 56 |
| OPM % | 46% | 51% | 52% | 31% | -7% | 12% | 13% | -22% | 26% | 39% | 41% | 35% |
| 1 | 5 | 2 | 10 | 7 | 2 | 3 | 7 | 4 | 6 | 5 | 8 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 4 | 3 | 3 | 4 | 4 | 4 | 5 | 5 | 5 |
| Profit before tax | 9 | 16 | 17 | 18 | 1 | 2 | 2 | -3 | 27 | 52 | 83 | 58 |
| Tax % | 30% | 29% | 18% | 16% | 81% | 7% | -57% | -43% | 29% | 25% | 25% | 27% |
| 7 | 11 | 14 | 15 | 0 | 2 | 3 | -2 | 19 | 39 | 62 | 42 | |
| EPS in Rs | 4.65 | 7.96 | 9.79 | 10.74 | 0.13 | 1.50 | 1.79 | -1.21 | 12.51 | 26.05 | 41.03 | 28.16 |
| Dividend Payout % | 45% | 47% | 48% | 16% | 309% | 0% | 0% | 0% | 8% | 8% | 10% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 42% |
| 3 Years: | 14% |
| TTM: | -22% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 77% |
| 3 Years: | 31% |
| TTM: | -30% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 32% |
| 3 Years: | 18% |
| 1 Year: | -24% |
| Return on Equity | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 27% |
| 3 Years: | 31% |
| Last Year: | 21% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 12 | 12 | 12 | 12 | 12 | 14 | 14 | 14 | 15 | 15 | 15 | 15 |
| Reserves | 10 | 16 | 30 | 38 | 36 | 44 | 46 | 44 | 73 | 111 | 170 | 206 |
| 0 | 0 | 0 | 0 | 0 | 5 | 4 | 4 | 3 | 0 | 0 | 2 | |
| 9 | 6 | 6 | 6 | 7 | 7 | 7 | 7 | 15 | 10 | 12 | 11 | |
| Total Liabilities | 31 | 33 | 47 | 56 | 55 | 70 | 71 | 69 | 106 | 136 | 196 | 234 |
| 5 | 5 | 16 | 16 | 13 | 17 | 15 | 14 | 12 | 15 | 17 | 18 | |
| CWIP | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 3 | 2 | 0 |
| Investments | 15 | 16 | 19 | 26 | 12 | 11 | 6 | 2 | 1 | 37 | 82 | 113 |
| 9 | 11 | 11 | 14 | 28 | 42 | 50 | 52 | 92 | 81 | 95 | 103 | |
| Total Assets | 31 | 33 | 47 | 56 | 55 | 70 | 71 | 69 | 106 | 136 | 196 | 234 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10 | 7 | 12 | 3 | -10 | 10 | -0 | 1 | 10 | 20 | 66 | 29 | |
| -11 | 3 | -12 | 1 | 14 | -23 | -0 | 0 | -18 | -16 | -58 | -27 | |
| -2 | -7 | -2 | -6 | -2 | 12 | -1 | -1 | 9 | -4 | -4 | -7 | |
| Net Cash Flow | -3 | 3 | -2 | -2 | 2 | -0 | -2 | 0 | 0 | -1 | 5 | -4 |
| Free Cash Flow | 6 | 8 | 1 | 1 | -11 | 1 | -2 | -3 | 7 | 9 | 60 | 27 |
| CFO/OP | 123% | 119% | 95% | 55% | 305% | 295% | 13% | -30% | 45% | 67% | 107% | 80% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 9 | 9 | 21 | 29 | 59 | 31 | 91 | 42 | 72 | 67 | 43 | 72 |
| Inventory Days | 72 | 155 | 225 | 200 | 77 | 92 | 136 | 215 | 103 | 155 | 85 | 125 |
| Days Payable | 171 | 182 | 238 | 101 | 43 | 74 | 71 | 107 | 59 | 19 | 24 | 23 |
| Cash Conversion Cycle | -90 | -19 | 8 | 128 | 93 | 48 | 156 | 150 | 116 | 203 | 103 | 174 |
| Working Capital Days | -102 | -35 | 8 | 60 | 83 | 16 | 74 | 63 | 76 | 115 | 65 | 285 |
| ROCE % | 46% | 64% | 48% | 39% | 2% | 6% | 4% | -4% | 36% | 49% | 53% | 29% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Benefit Expenses INR Lakhs |
|
||||||||||
| Total Granted Patents (Cumulative) Number |
|||||||||||
| Number of Employees Number |
|||||||||||
| FSSAI Approved Products (Avery Pharma) Number |
|||||||||||
| Prescription (Rx) Approved Products Number |
|||||||||||
| Registered Trademarks (India) Number |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
Press Release On Financial Result For The Financial Year Ended 31St March 2026
14h - Arrow Greentech reported FY26 revenue of Rs. 2,005 million, PAT of Rs. 474 million, and Rs. 5 dividend.
-
Intimation Of Grant Of Options To Identified Employees Under Employee Stock Option Plans
14h - Arrow Greentech granted 61,000 ESOP options at Rs 359 each, with minimum one-year vesting.
-
Board Meeting Outcome for Outcome Of Board Meeting Held On 22Nd May 2026
14h - Board approved FY26 audited standalone and consolidated results; recommended 50% dividend, Rs 5 per share.
-
Board Meeting Intimation for Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Year Ended On 31St March, 2026
18 May - Board meets 22 May 2026 for FY26 audited results and possible dividend recommendation.
-
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
29 Apr - Arrow Greentech confirms it is not a large corporate; outstanding borrowings were nil on 31 March 2026.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Concalls
-
Feb 2026TranscriptAI SummaryPPT
-
Nov 2025TranscriptAI SummaryPPT
-
Aug 2025TranscriptAI SummaryPPT
-
May 2025TranscriptAI SummaryPPT
-
Feb 2025TranscriptAI SummaryPPT
-
Oct 2024TranscriptAI SummaryPPT
-
May 2024TranscriptAI SummaryPPT
-
May 2024TranscriptAI SummaryPPT
-
May 2024TranscriptAI SummaryPPT
-
Feb 2024TranscriptAI SummaryPPT
-
Nov 2023TranscriptAI SummaryPPT
-
Jun 2023TranscriptAI SummaryPPT
-
Nov 2019TranscriptAI SummaryPPT
-
Feb 2019TranscriptAI SummaryPPT
-
Aug 2016TranscriptAI SummaryPPT
-
May 2016TranscriptAI SummaryPPT
-
Nov 2015TranscriptAI SummaryPPT
-
Aug 2015TranscriptAI SummaryPPT
Business Overview:[1][2]
AGL is India’s largest manufacturer of water-soluble films, specializing in the development, production, and marketing of a diverse range of PVA/PVOH-based films. Its portfolio includes innovative applications such as mouth dissolving strips for pharmaceutical and nutraceutical use. In addition to green packaging solutions, AGL also offers advanced security products and intellectual property services, positioning itself as a multi-vertical technology-driven company.